Action on prostate problems traditionally follows three paths, Baccala says: surveillance, active monitoring, and treatment when necessary. Certain prostate cancers won’t ever require treatment, which traditionally includes surgery and radiation. In addition to imaging, urologists also use genetics – DNA extracted from tumor tissue – to determine a patient’s risk level. “The genetic component is important,” Baccala says.
Focal One adds another treatment option but isn’t expected to become the dominant treatment choice. “It’s not for everyone, but if it’s not right for you, we will find the best and most effective treatment for your specific situation,” Baccala says. “There are a lot of options. You may not need treatment. There are better alternatives now that may not even require cutting.”
Men should know their family history of prostate cancer, and Baccala urges them not to be afraid to talk about the issue. “The earlier you get tested, the more options you have, and a lot of options carry very low side effects.”
Most prostate surgery today is robotically assisted, Baccala says. LVHN features single-port robotic surgery (one incision), which is minimally invasive, and patients go home the same day. Single-port prostate surgery is not available at many other health networks in the region, Baccala says.
“Men’s urologic issues in general, and prostate issues in particular, are getting a lot more attention today, and that’s a good thing,” Baccala says. “We want men to know they have a world-class partner in LVHN, with the best treatment options right here, close to home.”